Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine

Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine have?

Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine has 205 citations in the OpenAlex counts ScholarIQ stores.

When was Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine published?

Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine has 2018 year in the ScholarIQ index.

What is the open-access status of Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine?

Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine has bronze oa status in the ScholarIQ index.

What is the DOI of Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine?

The DOI for Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine is on the source record.

What is the PMID of Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine?

The PMID for Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine is on the source record.

What is the OpenAlex record for Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine?

The OpenAlex for Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine is on the source record.